التفاصيل البيبلوغرافية
| العنوان: |
An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasma Cholesterol-Lowering Activity in apoE-/- Mice. |
| المؤلفون: |
Vik, Rita, Busnelli, Marco, Parolini, Cinzia, Bjørndal, Bodil, Holm, Sverre, Bohov, Pavol, Halvorsen, Bente, Brattelid, Trond, Manzini, Stefano, Ganzetti, Giulia S., Dellera, Federica, Nygård, Ottar K., Aukrust, Pål, Sirtori, Cesare R., Chiesa, Giulia, Berge, Rolf K. |
| المصدر: |
PLoS ONE; Dec2013, Vol. 8 Issue 12, p1-1, 1p |
| مصطلحات موضوعية: |
IMMUNOREGULATION, FATTY acids, MITOCHONDRIAL physiology, ANTICHOLESTEREMIC agents, APOLIPOPROTEIN E, ANTILIPEMIC agents, PEROXISOME proliferator-activated receptors |
| مستخلص: |
Tetradecylthioacetic acid (TTA) is a hypolipidemic antioxidant with immunomodulating properties involving activation of peroxisome proliferator-activated receptors (PPARs) and proliferation of mitochondria. This study aimed to penetrate the effect of TTA on the development of atherosclerotic lesions in apolipoprotein (apo)-E-/- mice fed a high-fat diet containing 0.3% TTA for 12 weeks. These mice displayed a significantly less atherosclerotic development vs control. Plasma cholesterol was increased by TTA administration and triacylglycerol (TAG) levels in plasma and liver were decreased by TTA supplementation, the latter, probably due to increased mitochondrial fatty acid oxidation and reduced lipogenesis. TTA administration also changed the fatty acid composition in the heart, and the amount of arachidonic acid (ARA) and eicosapentaenoic acid (EPA) was reduced and increased, respectively. The heart mRNA expression of inducible nitric oxidase (NOS)-2 was decreased in TTA-treated mice, whereas the mRNA level of catalase was increased. Finally, reduced plasma levels of inflammatory mediators as IL-1α, IL-6, IL-17, TNF-α and IFN-γ were detected in TTA-treated mice. These data show that TTA reduces atherosclerosis in apoE-/- mice and modulates risk factors related to atherosclerotic disorders. TTA probably acts at both systemic and vascular levels in a manner independent of changes in plasma cholesterol, and triggers TAG catabolism through improved mitochondrial function. [ABSTRACT FROM AUTHOR] |
|
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder